The San Miguel de Allende clinic unifies maxillofacial surgery, implantology, and prosthetics for dentofacial cases ...
Talquetamab delivers high response rates in refractory myeloma; learn how to prevent skin, nail and oral side effects to stay on therapy. As the therapeutic arsenal for relapsed/refractory multiple ...
Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...
Annual Meeting, James Song, MD, chief medical officer and director of clinical research, Frontier Dermatology, outlines maj ...
Researchers in Japan developed an oral insulin pill that lowered blood sugar in diabetic mice, offering hope for a ...
Though this pattern is not just unique to Nigeria, but its consequences are particularly visible in countries where health systems already operate under pressure. When prevention is neglected, the ...
A common oral bacterium tied to gum disease may help spark and fuel breast cancer, according to new research. Scientists discovered it can travel through the bloodstream to breast tissue, where it ...
A new study looks at how estrogen changes during and after menopause affect hypertension and heart disease risk. Experts deliberate on how HRT may help.
Verastem (VSTM) stock receives a "Buy" rating, driven by progress in KRAS G12D-targeted therapies and multiple 2026 catalysts. Read the full analysis here.
Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on TradersPro’s Substack. In ...
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results